Retraction: Magnetic resonance imaging and 18F-fludeoxyglucose positron emission tomography/computed tomography findings of retroperitoneal clear cell carcinoma with an unknown primary site: a case report

, Frontiers Editorial Office

doi:10.3389/fmed.2023.1292298

RETRACTION article

Front. Med., 13 September 2023

Sec. Nuclear Medicine

Volume 10 - 2023 | https://doi.org/10.3389/fmed.2023.1292298

This article is part of the Research Topic Case reports in PET Imaging View all 14 articles

Retraction: Magnetic resonance imaging and ¹⁸F-fludeoxyglucose positron emission tomography/computed tomography findings of retroperitoneal clear cell carcinoma with an unknown primary site: a case report

This article is a retraction of:

RETRACTED: Magnetic resonance imaging and 18F-fludeoxyglucose positron emission tomography/computed tomography findings of retroperitoneal clear cell carcinoma with an unknown primary site: A case report
1. Read original article

$\r\nFrontiers Editorial Office$ Frontiers Editorial Office^*

A Retraction of the Case Report Article
Magnetic resonance imaging and ¹⁸F-fludeoxyglucose positron emission tomography/computed tomography findings of retroperitoneal clear cell carcinoma with an unknown primary site: a case report

by Zeng, D.-B., Chang, C., Liu, X.-S., Gao, Y., Wang, Y.-L., and Pei, Z.-J. (2022). Front. Med. 9:1024008. doi: 10.3389/fmed.2022.1024008

The journal retracts the 2022 article cited above.

Following concerns regarding the originality of the discussion in the article, an investigation was conducted in accordance with Frontiers' policies. It was found that the complaint was valid and that the article should be retracted, because of an unacceptable high level of similarity to the discussion section of a different case study (article published by Yang et al., 2022: Chin J Nucl Med Mol Imaging, 2022, 42(3):174–176. doi: 10.3760/cma.j.cn321828-20220206-00031).

This retraction was approved by the Chief Editors of Frontiers in Medicine and the Chief Executive Editor of Frontiers. The authors agree to this retraction.

Citation: Frontiers Editorial Office (2023) Retraction: Magnetic resonance imaging and ¹⁸F-fludeoxyglucose positron emission tomography/computed tomography findings of retroperitoneal clear cell carcinoma with an unknown primary site: a case report. Front. Med. 10:1292298. doi: 10.3389/fmed.2023.1292298

Received: 11 September 2023; Accepted: 11 September 2023;
Published: 13 September 2023.

Approved by:

Giorgio Treglia, Ente Ospedaliero Cantonale (EOC), Switzerland

Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5JiN4MDAwNDA7ZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.